Search results
Results from the WOW.Com Content Network
Price Action: REGN shares closed at $1,050.86 on Thursday. "ACTIVE INVESTORS' SECRET WEAPON" Supercharge Your Stock Market Game with the #1 "news & everything else" trading tool: Benzinga Pro ...
On Thursday, Regeneron Pharmaceuticals Inc (NASDAQ:REGN) reported third-quarter adjusted EPS of $12.46, up 8% year-over-year, beating the consensus of $11.69. The company reported sales of $3.72 ...
Would a stock split help lead Regeneron Pharmaceuticals shares higher?
Regeneron (REGN) closed at $615.88 in the latest trading session, marking a -0.8% move from the prior day. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...
Top Stock Reports for Oracle, Intuit & Regeneron Pharmaceuticals
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...
Regeneron reported an adjusted profit of $11.56 per share on total revenue of $3.55 billion for the quarter, above analysts' estimates of $10.61 per share and $3.38 billion, according to LSEG data.
Video. Follow Us. Regeneron stock surges on positive results in eye disease drug trial. September 8, 2022 at 12:57 PM ...